The latest on COVID-19

Tufts Medicine is closely following the spread of COVID-19. In these unprecedented times, the safety and well-being of our patients, communities, employees and physicians is our greatest priority. Access the latest COVID-19 vaccine information in multiple languages and learn how we are keeping you safe with us.

COVID-19 Vaccine

The vaccine is a step in our fight against COVID-19 and in returning to a more normal way of life. It is natural, as with any medication or treatment, that people have questions about it. View the facts and resources provided by our infectious diseases doctors.

Safe With Us

Our members – Circle Health, Home Health Foundation, MelroseWakefield Healthcare, Tufts Medical Center and Tufts Children's Hospital – have dedicated their lives to keeping all patients and employees healthy and safe and continuously are collaborating to ensure they are Safe with Us. 

Practice Resources

We remain committed to providing clinical, operational, economic and emotional support for our ambulatory practices. View the latest ambulatory practice resources including diagnostic testing, vaccines, prevention, boosters, helpful templates and more.

Get Your Booster Today! It's Worth the Shot!

Increasing evidence shows the booster dose works very effectively at bringing down rates of infection, hospitalization and death in those who received them. Now is the time to get your booster. 

Learn more

Recent News 

*As of 1/12/22

New COVID-19 SMART Health Card Verifies Your Vaccination Status

Massachusetts residents who were vaccinated in-state can now request, view, and/or print their own COVID-19 SMART Health card. This will allow those who have been received the COVID-19 vaccine the ability to create a digitally formatted certification with a QR Code that verifies their immunization status. Learn more

Omicron Variant Now Predominant

The Omicron variant is now predominant in Massachusetts and has managed to outcompete the Delta variant due to its very high transmissibility and its ability to evade the immune response given by vaccination and prior infection. COVID-19 case numbers are as high as they have ever been throughout the pandemic. But there is some good news. Basic science research suggests that there is reason to believe that the Omicron variant is less capable of infecting lung cells and thus causing severe disease. Data from several countries shows the case-to-hospitalization rate is lower with Omicron than it was with Delta (meaning people are less likely to be hospitalized).

New CDC Recommendations for Isolation and Quarantine

CDC has substantially changed the recommendations for Isolation (symptomatic illness or positive test) and Quarantine (COVID-19 exposure) for the general public. Massachusetts has adopted this new guidance from the CDC. Learn more.

Two Antiviral Pills Authorized

Two at-home pill treatments for COVID-19 have been authorized by the Food and Drug Administration for patients who test positive for the coronavirus. An antiviral pill treatment from Pfizer was authorized on Wednesday, December 22, and another from Merck was approved on Thursday, December 23. Stay tuned for more information on treatment availability.